4.8 (655) · € 20.00 · En Stock
Amid headwinds in 2024, pharma should reinvent their business model to offer compelling outcomes for patients and investors.
Amid headwinds in 2024, pharma should reinvent their business model to offer compelling outcomes for patients and investors.
Modernized supply chain strategy: PwC
Life Sciences' Shifting Sands: 5 Trends that Threaten the Status Quo - Schlafender Hase
Pharmaceutical Industry Industry Overview: Trends, Risks, Opportunities & Deals
The Cost of Treating Patients is On the Rise: PwC Goes What's Behind the 2024 Medical Spending Numbers
Pharma industry trends: PwC
Pharma industry trends: PwC
IJERPH, Free Full-Text
PwC 2023 Global M&A Industry Trends Outlook
PwC Interview - Italy Life Sciences 2021
Healthcare trends: PwC
Pharmaceuticals and life sciences services & insights
Payers should brace for healthcare cost hike, PwC says
Next in Health (podcast) - PwC's Health Research Institute